Tag: WHO
MSIF’s work on access to MS healthcare
Addressing barriers to accessing MS healthcare at a global, regional and national level.
Relevant publications
Publications from MSIF and other stakeholders in support of work on access to MS healthcare.
The WHO Intersectoral Global Action Plan for epilepsy and other neurological disorders
A 10-year global action plan that aims to improve the lives of people living with neurological conditions including MS
La decisión de la OMS trae esperanza a personas con esclerosis múltiple de todo el mundo
Multiple Sclerosis (MS) treatments added to WHO’s Essential Medicines List for the first time
MSIF insiste en la necesidad de tratamientos para las afecciones neurológicas durante la reunión de la OMS
MSIF and neurological organisations' statement during the Essential Medicines List Committee open session
Essential medicines for MS
Advocating for the addition of MS treatments to the WHO Essential Medicines List
Solicitud de la MSIF para la Lista de Medicamentos Esenciales
Efforts to improve access to MS treatments continue
Improving access to MS treatment and healthcare
Addressing barriers to accessing treatment at a global, regional and national level
La Asamblea Mundial de la Salud aprobó un importante plan mundial de 10 años para mejorar la atención a las personas afectadas por enfermedades neurológicas
MSIF supports the adoption of the WHO's intersectoral global action plan on epilepsy and other neurological disorders, including MS
El movimiento MSIF da forma al plan de acción mundial de la OMS para la epilepsia y otros trastornos neurológicos
MSIF highlights priority actions for MS in the draft global plan